SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-043557
Filing Date
2024-05-15
Accepted
2024-05-15 16:01:03
Documents
32
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0205711-10q_raphael.htm   iXBRL 10-Q 289986
2 CERTIFICATION ea020571101ex31-1_raph.htm EX-31.1 7994
3 CERTIFICATION ea020571101ex31-2_raph.htm EX-31.2 7725
4 CERTIFICATION ea020571101ex32-1_raph.htm EX-32.1 3218
5 CERTIFICATION ea020571101ex32-2_raph.htm EX-32.2 3189
  Complete submission text file 0001213900-24-043557.txt   1325353

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE raph-20240331.xsd EX-101.SCH 18691
7 XBRL CALCULATION FILE raph-20240331_cal.xml EX-101.CAL 13032
8 XBRL DEFINITION FILE raph-20240331_def.xml EX-101.DEF 57732
9 XBRL LABEL FILE raph-20240331_lab.xml EX-101.LAB 141955
10 XBRL PRESENTATION FILE raph-20240331_pre.xml EX-101.PRE 63235
36 EXTRACTED XBRL INSTANCE DOCUMENT ea0205711-10q_raphael_htm.xml XML 59649
Mailing Address SUITE 105 - 5348 VEGAS DR. LAS VEGAS NV 89108
Business Address SUITE 105 - 5348 VEGAS DR. LAS VEGAS NV 89108 702-442-1166
Raphael Pharmaceutical Inc. (Filer) CIK: 0001415397 (see all company filings)

IRS No.: 260204284 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53002 | Film No.: 24950098
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)